These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23957267)

  • 21. Stimuli-responsive liposome-nanoparticle assemblies.
    Preiss MR; Bothun GD
    Expert Opin Drug Deliv; 2011 Aug; 8(8):1025-40. PubMed ID: 21663539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomal drug delivery, a novel approach: PLARosomes.
    Kozubek A; Gubernator J; Przeworska E; Stasiuk M
    Acta Biochim Pol; 2000; 47(3):639-49. PubMed ID: 11310966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposomal antibiotics for the treatment of infectious diseases.
    Alhariri M; Azghani A; Omri A
    Expert Opin Drug Deliv; 2013 Nov; 10(11):1515-32. PubMed ID: 23886421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in tumor vasculature targeting using liposomal drug delivery systems.
    Abu Lila AS; Ishida T; Kiwada H
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1297-309. PubMed ID: 19780711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilization of liposomes during drying.
    Ingvarsson PT; Yang M; Nielsen HM; Rantanen J; Foged C
    Expert Opin Drug Deliv; 2011 Mar; 8(3):375-88. PubMed ID: 21294603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.
    Zylberberg C; Matosevic S
    Drug Deliv; 2016 Nov; 23(9):3319-3329. PubMed ID: 27145899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide-based cationic liposome-mediated gene delivery.
    Zhao Y; Zhang S; Cui S; Wang B; Zhang S
    Expert Opin Drug Deliv; 2012 Jan; 9(1):127-39. PubMed ID: 22103714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity.
    Gubernator J
    Expert Opin Drug Deliv; 2011 May; 8(5):565-80. PubMed ID: 21492058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Niosomes in sustained and targeted drug delivery: some recent advances.
    Azeem A; Anwer MK; Talegaonkar S
    J Drug Target; 2009 Nov; 17(9):671-89. PubMed ID: 19845484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
    Lopez-Barcons LA; Polo D; Reig F; Fabra A
    J Biomed Mater Res A; 2004 Apr; 69(1):155-63. PubMed ID: 14999763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents.
    Kumar A; Pathak K; Bali V
    Drug Discov Today; 2012 Nov; 17(21-22):1233-41. PubMed ID: 22766375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current trends in liposome research.
    Elbayoumi TA; Torchilin VP
    Methods Mol Biol; 2010; 605():1-27. PubMed ID: 20072870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.
    Almeida B; Nag OK; Rogers KE; Delehanty JB
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33271886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH-sensitive liposomes for drug delivery in cancer treatment.
    Ferreira Ddos S; Lopes SC; Franco MS; Oliveira MC
    Ther Deliv; 2013 Sep; 4(9):1099-123. PubMed ID: 24024511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomal Drug Delivery and Its Potential Impact on Cancer Research.
    Bhattacharya S; Saindane D; Prajapati BG
    Anticancer Agents Med Chem; 2022 Aug; 22(15):2671-2683. PubMed ID: 35440318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications.
    Panahi Y; Farshbaf M; Mohammadhosseini M; Mirahadi M; Khalilov R; Saghfi S; Akbarzadeh A
    Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):788-799. PubMed ID: 28278586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.